Search

everythinglearnresearchcommunity

for

Search:↓

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

JAK inhibitors show promise for treating various skin diseases.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

Corticosteroids and topical irritants are used to treat alopecia areata.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Improving nerve and immune interactions may help heal chronic wounds.

New and repurposed treatments are improving outcomes in dermatology.

Low-output laser irradiation can stimulate or inhibit biological processes depending on the dose.

NK cells play a role in skin diseases like eczema and psoriasis.

Belatacept may be a promising treatment for alopecia areata.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

The skin's immune system helps it regenerate and fight infections.

Apremilast did not work for treating severe alopecia areata.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Systemic steroids can effectively treat alopecia areata with manageable side effects.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.